Mesoblast shares tumble on failed Covid-19 trial
MELBOURNE: Shares in stem cell-focused biotech Mesoblast have tumbled more than 4 per cent after
MELBOURNE: Shares in stem cell-focused biotech Mesoblast have tumbled more than 4 per cent after